PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centers ...
2026-05-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
BEIJING, HANGZHOU, China and CAMBRIDGE, Mass. , May 20, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a global leader in AI-powered drug delivery innovation, today announced that new preclinical data ...
2026-05-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Celebrate National Physical Fitness & Sports Month: Breathe Better, Move Freely with Oxygen Support
NEW YORK , May 20, 2026 /PRNewswire/ -- May is National Physical Fitness & Sports Month , a time to celebrate staying active and prioritizing health at every stage of life. VARON , a leading ...
2026-05-20T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Hyundai Bioscience: "Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread"
SEOUL, South Korea , May 20, 2026 /PRNewswire/ -- Hyundai Bioscience announced on May 19th that it can supply clinical trial doses of its broad-spectrum antiviral drug XAFTY ® in response to ...
2026-05-20T    Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization
TOKYO , May 20, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), recently hosted its third CRDMO Day in Tokyo, bringing ...
2026-05-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research
Collaboration expands research of new delivery platform beyond liver tissues supporting potential preclinical development and strengthens Singapore's position as a biomedical innovation hub ...
2026-05-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ATxSummit 2026 Opens with Shared Regional Ambition to Harness AI for Public Good
SINGAPORE , May 20, 2026 /PRNewswire/ -- ATxSummit 2026, hosted by the Infocomm Media Development Authority of Singapore, officially kicked off this evening with Singapore President Tharman Shanmugaratnam ...
2026-05-20T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
SHANGHAI and HONG KONG , May 20, 2026 /PRNewswire/ -- Antengene Corporation Limited  ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ...
2026-05-20T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
PRC-Saltillo Named to Forbes Accessibility 200 List
WOOSTER, Ohio , May 20, 2026 /PRNewswire/ -- PRC-Saltillo has been named to the 2026 Forbes Accessibility 200 list , an annual list recognizing companies and individuals worldwide whose work is ...
2026-05-20T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening ...
2026-05-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.